Jennifer Liang
Otolaryngology · Alexandria, VANPI 1811457955
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (56.8%), food and beverage and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Stryker at 47.1% of the total.
Across 71 payments — averaging $53.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Inspire Medical Systems, Inc.$806
- GSK$220
- Regeneron Healthcare Solutions, Inc.$185
- Medtronic$177
- Aerin Medical Inc.$174
- plus $437 from 6 others
What the payments were for
- Travel & lodging$2,14657%
- Food & beverage$1,61243%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 12 | $1,778 |
| Inspire Medical Systems, Inc. | 22 | $806 |
| GSK | 7 | $220 |
| Regeneron Healthcare Solutions, Inc. | 8 | $185 |
| Medtronic | 4 | $177 |
| Aerin Medical Inc. | 3 | $174 |
| Sanofi | 3 | $152 |
| Optinose US, Inc. | 5 | $130 |
| Paratek Pharmaceuticals, Inc. | 3 | $76 |
| Amgen | 2 | $32 |
| Johnson & Johnson | 1 | $24 |
| 3b Medical, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SCOPIS ENT$1,376
- Inspire$533
- VIVAER STYLUS$130
- RHINAER STYLUS$130
How this compares
$3,776 in reported general payments places this provider in the 80th percentile of 241 otolaryngology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ofloxacin | 12 | $469 |
| Fluticasone Propionate | 34 | $317 |
| Azelastine Hcl | 14 | $283 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $71 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Alexandria
- Stanley VoigtAlexandria$6K
- Richard ComstockAlexandria$5K
- Ravi SwamyAlexandria$4K
- Laurence OhalloranAnnandale$2.9M
- Joseph HanNorfolk$1.8M
- Ryan NordRichmond$454K
- Paul LenkowskiRoanoke$282K
- Nipun ChhabraLeesburg$178K
- Kent LamNorfolk$127K
- Spencer PayneCharlottesville$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.